Lees, R.S. and Hatch, F.T.: Sharper separation of lipoprotein species by paper electrophoresis in albumin-containing buffer. T Lab &Clin. Med.61: 518 March, 1963.
2.
Lees, R.S. and Fredrickson, D.S. : Differentiation of exogenous and endogenous hyperlipemia by paper electrophoresis. J. Clin. Investigation44: 1968-1977, 1965.
3.
Naale, Robert P.: Electrophoretic separation of plasma lipoproteins in agarose gel. T. Lipid Res.9: 693-700, 1968.
4.
Chin, H.P. and Blansenhorn, D.H. : Separation and quantitative analysis of serum lipoproteins by means of electrophoresis on cellulose acetate. Clin Chem Acta18: 324-334,1967.
5.
Kannel, W.B. , Costelli, W.P. and McNamara, P.M.: The Coronary Profile: 12-year follow-up in the Framingham Study. J. Occup. Med.9: 611-619 December, 1967.
6.
Kannel, W.B.: Normal Limits for Serum Cholesterol. from Treatment of the Hyperlipidemic States, Casdorph, H. R. (Ed.), Thomas, Springfield, 1970. In Press.
7.
Connor, W.B.: Dietary Treatment of the Hyperlipidemic States. from Treatment of the Hyperlipidemic States, Casdorph, H. R. (Ed.), Thomas, Springfield, 1970, In Press.
8.
Parsons, W.B. , Jr.: Effect of Nicotinic Acid and aluminum Nicotinate in Type II Hyperlipoproteinemia. Circulation, 35: II-30, 1967.
9.
Levy, R.I. et al.: The Efficiency of Clofibrate (CPIB) in Familial Hyperlipoproteinemias ., Presented at 3rd International Symposium on Drugs affecting Lipid Metabolism. Sept., 1968, Milan, Italy.
10.
Langer, T. and Levy, R.I.: Acute Muscular Syndrome Associated with Administration of Clofibrate. New EngJ. Med.279: 856-858 (Oct. 17) 1968.
11.
Owen, W.R. et al.: Effect of Sodium Dextrothyroxine on Serum Cholesterol in Man . JAMA, 178: 1036, 1961.
12.
Cohen, B.M. : Clinical use of Dextrothyroxine in Hypercholesterolemic States: 8-year appraisal. J. Clin. Pharmacal9: 45-56, 1969.
13.
Buchwald, H. : A surgical operation to lower circulating cholesterol . Circ., 28 Part II: 649, 1963.